BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35941130)

  • 1. Cytosine base editing systems with minimized off-target effect and molecular size.
    Li A; Mitsunobu H; Yoshioka S; Suzuki T; Kondo A; Nishida K
    Nat Commun; 2022 Aug; 13(1):4531. PubMed ID: 35941130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing.
    Nguyen Tran MT; Mohd Khalid MKN; Wang Q; Walker JKR; Lidgerwood GE; Dilworth KL; Lisowski L; Pébay A; Hewitt AW
    Nat Commun; 2020 Sep; 11(1):4871. PubMed ID: 32978399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-Target Editing by CRISPR-Guided DNA Base Editors.
    Park S; Beal PA
    Biochemistry; 2019 Sep; 58(36):3727-3734. PubMed ID: 31433621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Fidelity Cytosine Base Editing in a GC-Rich Corynebacterium glutamicum with Reduced DNA Off-Target Editing Effects.
    Heo YB; Hwang GH; Kang SW; Bae S; Woo HM
    Microbiol Spectr; 2022 Dec; 10(6):e0376022. PubMed ID: 36374037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Base editors for simultaneous introduction of C-to-T and A-to-G mutations.
    Sakata RC; Ishiguro S; Mori H; Tanaka M; Tatsuno K; Ueda H; Yamamoto S; Seki M; Masuyama N; Nishida K; Nishimasu H; Arakawa K; Kondo A; Nureki O; Tomita M; Aburatani H; Yachie N
    Nat Biotechnol; 2020 Jul; 38(7):865-869. PubMed ID: 32483365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status and Challenges of DNA Base Editing Tools.
    Jeong YK; Song B; Bae S
    Mol Ther; 2020 Sep; 28(9):1938-1952. PubMed ID: 32763143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
    Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
    Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing.
    Grünewald J; Zhou R; Lareau CA; Garcia SP; Iyer S; Miller BR; Langner LM; Hsu JY; Aryee MJ; Joung JK
    Nat Biotechnol; 2020 Jul; 38(7):861-864. PubMed ID: 32483364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sgBE: a structure-guided design of sgRNA architecture specifies base editing window and enables simultaneous conversion of cytosine and adenosine.
    Wang Y; Zhou L; Tao R; Liu N; Long J; Qin F; Tang W; Yang Y; Chen Q; Yao S
    Genome Biol; 2020 Aug; 21(1):222. PubMed ID: 32859244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliminating predictable DNA off-target effects of cytosine base editor by using dual guiders including sgRNA and TALE.
    Zhou J; Liu Y; Wei Y; Zheng S; Gou S; Chen T; Yang Y; Lan T; Chen M; Liao Y; Zhang Q; Tang C; Liu Y; Wu Y; Peng X; Gao M; Wang J; Zhang K; Lai L; Zou Q
    Mol Ther; 2022 Jul; 30(7):2443-2451. PubMed ID: 35443934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.
    Kweon J; Jang AH; Kwon E; Kim U; Shin HR; See J; Jang G; Lee C; Koo T; Kim S; Kim Y
    Exp Mol Med; 2023 Feb; 55(2):377-384. PubMed ID: 36720917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internally inlaid SaCas9 base editors enable window specific base editing.
    Jiang L; Long J; Yang Y; Zhou L; Su J; Qin F; Tang W; Tao R; Chen Q; Yao S
    Theranostics; 2022; 12(10):4767-4778. PubMed ID: 35832085
    [No Abstract]   [Full Text] [Related]  

  • 13. A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects.
    Zuo E; Sun Y; Yuan T; He B; Zhou C; Ying W; Liu J; Wei W; Zeng R; Li Y; Yang H
    Nat Methods; 2020 Jun; 17(6):600-604. PubMed ID: 32424272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
    Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
    BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TadA orthologs enable both cytosine and adenine editing of base editors.
    Zhang S; Yuan B; Cao J; Song L; Chen J; Qiu J; Qiu Z; Zhao XM; Chen J; Cheng TL
    Nat Commun; 2023 Jan; 14(1):414. PubMed ID: 36702837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex genome editing using a dCas9-cytidine deaminase fusion in Streptomyces.
    Zhao Y; Tian J; Zheng G; Chen J; Sun C; Yang Z; Zimin AA; Jiang W; Deng Z; Wang Z; Lu Y
    Sci China Life Sci; 2020 Jul; 63(7):1053-1062. PubMed ID: 31872379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous Expression and Purification of a CRISPR-Cas9-Based Adenine Base Editor.
    Lee SN; Jang HS; Woo JS
    Methods Mol Biol; 2023; 2606():123-133. PubMed ID: 36592312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.